A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/55 (2006.01) A61K 31/00 (2006.01) A61K 31/335 (2006.01) A61K 31/45 (2006.01) A61P 27/02 (2006.01) A61P 27/14 (2006.01) C07D 313/12 (2006.01)
Patent
CA 2195094
Topical ophthalmic formulations of the invention contain as an active ingredient 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2- acetic acid or a pharmaceutically acceptable salt thereof. The formulations are useful for treating allergic eye diseases such as allergic conjunctivitis, vernal conjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis.
Cette invention concerne des compositions ophtalmiques topiques contenant, en qualité d'ingrédient actif, de l'acide 11-(3-diméthylaminopropylidène)-6,11-dihydrodibenz[b,e]oxépin-2-acétique, ou un de ses sels acceptable sur le plan pharmaceutique. Ces compositions sont utiles dans le traitement d'affections allergiques des yeux, telles que la conjonctivite allergique, la conjonctivite printanière, la kératoconjonctivite printanière, et la conjonctivite papillaire géante.
Hayakawa Eiji
Nakakura Masashi
Robertson Stella M.
Yanni John Micheal
Alcon Laboratories Inc.
Alcon Research Ltd.
Kyowa Hakko Kirin Co. Ltd.
Kyowa Hakko Kogyo Co. Ltd.
Smart & Biggar
LandOfFree
Topical ophthalmic formulations containing doxepin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical ophthalmic formulations containing doxepin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical ophthalmic formulations containing doxepin... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1976965